ACVR2B and Huntington disease: The deposition of aggregated forms of the HTT protein is the earliest phenotype to have been reported in the skeletal muscle of HD mouse models36, and therefore it was important to determine whether treatment with ACVR2B/Fc might have modulated this process, which would potentially be indicative of disease modifying properties.